Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Study: No one spends more on healthcare than the U.S. government

The U.S. government spends more money on healthcare than any other nation in the world, including countries with universal healthcare programs such as Canada and the U.K., according to a study published online Jan. 21 in the American Journal of Public Health.

Learn about the revamped eCQI Resource Center

The Centers for Medicare & Medicaid Services has reintroduced its eCQI Resource Center, which serves as a one-stop shop for the most current resources to support electronic clinical quality improvement.

Healthcare management platform Spreemo announces new VP

Spreemo, a New York-based Healthcare management platform, announced this week it has named Daniel Elgort, PhD, its new vice president of healthcare analytics. 

Thumbnail

Infographic: Inside the healthcare construction boom

Expansions, renovations, brand-new facilities—the healthcare construction boom is underway, and providers across the country are getting in on the action.

Thumbnail

Shorter stays help hospitals’ bottom lines

Since 1980, the average hospital stay in the U.S. has decreased from 7.3 days to 4.5 days, the New York Times reports. Austin Frakt, a health economist, notes discharging patients sooner helps hospitals from a financial perspective.

Epic, Mayo Clinic enter into $46M agreement for data center

After announcing its plans to switch to Epic EHR and revenue cycle systems, Rochester, Minn.-based Mayo Clinic now plans to sell the IT vendor its 62,000-square-foot data center.

Thumbnail

Bringing 'Moneyball' to healthcare

A big sign of just how much impact data analytics is having on healthcare is the announcement that one of the Major League Baseball executives from the "Moneyball"-era has joined the faculty of the Scripps Translational Science Institute (STSI). 

What 'big ideas' will 2016 bring?

With 2016 just days away, various experts at the University of California-San Francisco (UCSF) were asked about the immediate future of scientific research. What diseases will we be closer to curing next year? How will science impact treatment?

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.